The global Cancer Biomarkers Market, valued at USD 22 billion in 2023, is anticipated to experience significant growth, reaching an estimated USD 52.18 billion by 2031. This projection represents a robust compound annual growth rate (CAGR) of 11.4% over the forecast period from 2024 to 2031. Key Players The major key players are F. Hoffmann-La Roche Ltd. (Switzerland), Thermo...